Ameriprise’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.19M Buy
59,244
+35,582
+150% +$714K ﹤0.01% 3168
2025
Q1
$466K Sell
23,662
-11,397
-33% -$224K ﹤0.01% 3484
2024
Q4
$789K Buy
+35,059
New +$789K ﹤0.01% 3317